ATE298328T1 - Taxan-derivate für die behandlung von krebs - Google Patents

Taxan-derivate für die behandlung von krebs

Info

Publication number
ATE298328T1
ATE298328T1 AT01918514T AT01918514T ATE298328T1 AT E298328 T1 ATE298328 T1 AT E298328T1 AT 01918514 T AT01918514 T AT 01918514T AT 01918514 T AT01918514 T AT 01918514T AT E298328 T1 ATE298328 T1 AT E298328T1
Authority
AT
Austria
Prior art keywords
cancer
treatment
taxan derivatives
derivatives
taxan
Prior art date
Application number
AT01918514T
Other languages
English (en)
Inventor
John F Kadow
Wendy S Schwartz
Paul M Scola
Qiufen May Xue
Mark D Wittman
Mu-Jen Wu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE298328T1 publication Critical patent/ATE298328T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01918514T 2000-03-17 2001-03-09 Taxan-derivate für die behandlung von krebs ATE298328T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19017400P 2000-03-17 2000-03-17
PCT/US2001/007666 WO2001070718A1 (en) 2000-03-17 2001-03-09 Taxane anticancer agents

Publications (1)

Publication Number Publication Date
ATE298328T1 true ATE298328T1 (de) 2005-07-15

Family

ID=22700293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918514T ATE298328T1 (de) 2000-03-17 2001-03-09 Taxan-derivate für die behandlung von krebs

Country Status (9)

Country Link
US (1) US6362217B2 (de)
EP (1) EP1263749B1 (de)
JP (1) JP2003528091A (de)
AT (1) ATE298328T1 (de)
AU (2) AU4558201A (de)
CA (1) CA2400645A1 (de)
DE (1) DE60111614T2 (de)
ES (1) ES2242741T3 (de)
WO (1) WO2001070718A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916942B2 (en) * 2000-02-03 2005-07-12 Bristol-Myers Squibb Company Process for the preparation of C-4 carbonate taxanes
UY27185A1 (es) * 2001-02-28 2002-09-30 Bristol Myers Squibb Co Dosificación metronómica de taxanos
JP4484108B2 (ja) * 2002-05-16 2010-06-16 塩野義製薬株式会社 Ｐｇｄ２受容体拮抗作用を有する化合物
JP4954983B2 (ja) 2005-05-18 2012-06-20 ファーマサイエンス・インコーポレイテッド Ｂｉｒドメイン結合化合物
CN101535300B (zh) 2006-05-16 2014-05-28 埃格拉医疗公司 Iap bir域结合化合物
CN101735179B (zh) * 2008-11-19 2012-09-12 上海百灵医药科技有限公司 一种多烯紫杉醇的制备方法，其中间体及制备方法
CN102985439B9 (zh) 2010-02-12 2016-08-03 制药科学股份有限公司 Iap bir结构域结合化合物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4960790A (en) 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
MY110249A (en) 1989-05-31 1998-03-31 Univ Florida State Method for preparation of taxol using beta lactam
KR960000442B1 (ko) 1990-11-26 1996-01-06 미쓰비시덴키 가부시키가이샤 이온전류 검출장치
US5990325A (en) * 1993-03-05 1999-11-23 Florida State University Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
US5283253A (en) 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5478854A (en) 1992-10-01 1995-12-26 Bristol-Myers Squibb Company Deoxy taxols
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
IL108443A0 (en) 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
US6187916B1 (en) * 1993-02-01 2001-02-13 Research Foundation Of State University Of New York Process for the preparation of taxane derivatives and β-lactam intermediates therefor
US6232477B1 (en) * 1996-03-25 2001-05-15 Aventis Pharma S.A. Methods of preparing new taxoids and pharmaceutical compositions containing them
EP0682660B1 (de) * 1993-02-05 2003-11-05 Bryn Mawr College Synthese von taxol, seinen analogen und intermediaten mit variablen a-ring seitenketten
DE69424166T2 (de) 1993-06-11 2000-10-05 Pharmacia & Upjohn Co., Kalamazoo Delta 6, 7-taxolen, antineoplastische verwendung und diese enthaltende pharmazeutische zusammenstellungen
FR2712289B1 (fr) * 1993-11-08 1996-01-05 Rhone Poulenc Rorer Sa Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
PT738148E (pt) * 1994-01-11 2002-11-29 Scripps Research Inst Nanoestruturas taxo-diterpenoides auto-construidas
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
US6248572B1 (en) * 1995-04-27 2001-06-19 Samyang, Genex, Corporation Production of taxol from taxus plant cell culture adding silver nitrate
BR9608040B1 (pt) * 1995-04-28 2010-02-23 composto taxàide pentacÍclico.
US6245805B1 (en) 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
CZ297979B6 (cs) * 1996-03-12 2007-05-16 Pg-Txl Company, L. P. Kompozice obsahující protinádorové lécivo konjugované s ve vode rozpustným polymerem, její pouzití pro výrobu léciva a implantovatelná lékarská pomucka
US5773461A (en) 1996-06-06 1998-06-30 Bristol-Myers Squibb Company 7-deoxy-6-substituted paclitaxels
CA2188190A1 (en) * 1996-10-18 1998-04-18 Sarala Balachandran The semi-synthesis of a protected bacatin iii compound
US5977386A (en) 1996-12-24 1999-11-02 Bristol-Myers Squibb Company 6-thio-substituted paclitaxels
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US7288665B1 (en) * 1997-08-18 2007-10-30 Florida State University Process for selective derivatization of taxanes
WO1999032473A1 (fr) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Derives de taxane
US6229207B1 (en) * 2000-01-13 2001-05-08 Advanced Micro Devices, Inc. Organic pin grid array flip chip carrier package
US6281368B1 (en) * 2000-03-16 2001-08-28 Napro Biotherapeutics, Inc. Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III

Also Published As

Publication number Publication date
US6362217B2 (en) 2002-03-26
US20020016356A1 (en) 2002-02-07
JP2003528091A (ja) 2003-09-24
WO2001070718A1 (en) 2001-09-27
EP1263749B1 (de) 2005-06-22
ES2242741T3 (es) 2005-11-16
AU4558201A (en) 2001-10-03
DE60111614D1 (de) 2005-07-28
DE60111614T2 (de) 2006-05-11
EP1263749A4 (de) 2003-06-18
EP1263749A1 (de) 2002-12-11
CA2400645A1 (en) 2001-09-27
AU2001245582B2 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
SE0301700D0 (sv) Novel compounds
ES2176212T3 (es) Eteres de fosfonooximetilicos o metiltiometilicos de derivados de taxano como agentes antitumorales.
IS6658A (is) Ný efnasambönd
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
SE0302811D0 (sv) Novel compounds
ATE433447T1 (de) Pyrimiidinverbindungen
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
TR200200768T2 (tr) Yeni kuinüklidin türevleri ve bunu içeren ilaç bileşimleri
SE0202539D0 (sv) Compounds
NO20024005D0 (no) Pteridinforbindelser for behandling av psoriasis
SE0104140D0 (sv) Novel Compounds
ES2243579T3 (es) Derivados de pirazolopirideno.
ATE364043T1 (de) Pyrazolo-pyridine für die behandlung von herpes- ansteckungen
HUP0400648A2 (hu) Ecteinascidin-743-t tartalmazó tumorellenes kezeléseknél alkalmazható készítmények
ATE405568T1 (de) Cytotoxische mittel
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
SE0102716D0 (sv) Novel compounds
MX9601994A (es) Profarmacos de derivados de paclitaxel.
DE60111614D1 (de) Taxan-derivate für die behandlung von krebs
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
SE0300457D0 (sv) Novel compounds
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
TW200504051A (en) Novel acridine derivatives and their use as medicaments

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1263749

Country of ref document: EP

REN Ceased due to non-payment of the annual fee